These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26120957)

  • 21. Clinical correlates of B-type natriuretic peptide monitoring in outpatients with left ventricular assist device.
    Hegarova M; Kubanek M; Netuka I; Maly J; Dorazilova Z; Gazdic T; Franekova J; Lanska V; Melenovsky V; Kautzner J; Malek I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Mar; 161(1):68-74. PubMed ID: 28266662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effect of Left Ventricular Assist Device Therapy on Cardiac Biomarkers: Implications for the Identification of Myocardial Recovery.
    Holzhauser L; Kim G; Sayer G; Uriel N
    Curr Heart Fail Rep; 2018 Aug; 15(4):250-259. PubMed ID: 29971612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B-type natriuretic peptide levels and continuous-flow left ventricular assist devices.
    Sareyyupoglu B; Boilson BA; Durham LA; McGregor CG; Daly RC; Redfield MM; Edwards BS; Frantz RP; Pereira NL; Park SJ
    ASAIO J; 2010; 56(6):527-31. PubMed ID: 21245799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients.
    Post F; Weilemann LS; Messow CM; Sinning C; Münzel T
    Crit Care Med; 2008 Nov; 36(11):3030-7. PubMed ID: 18824903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcome of high-urgency heart transplant patients with and without temporary ventricular assist device support.
    Castel MA; Cartañá R; Cardona M; Pereda D; Hernández M; Sandoval E; Castella M; Pérez-Villa F
    Transplant Proc; 2012 Nov; 44(9):2642-4. PubMed ID: 23146481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CentriMag short-term ventricular assist as a bridge to solution in patients with advanced heart failure: use beyond 30 days.
    Mohite PN; Zych B; Popov AF; Sabashnikov A; Sáez DG; Patil NP; Amrani M; Bahrami T; DeRobertis F; Maunz O; Marczin N; Banner NR; Simon AR
    Eur J Cardiothorac Surg; 2013 Nov; 44(5):e310-5. PubMed ID: 23990618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices.
    Enriquez AD; Calenda B; Miller MA; Anyanwu AC; Pinney SP
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):668-74. PubMed ID: 23873139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association of pretransplant HeartMate II left ventricular assist device placement and heart transplantation mortality.
    Donneyong M; Cheng A; Trivedi JR; Schumer E; McCants KC; Birks EJ; Slaughter MS
    ASAIO J; 2014; 60(3):294-9. PubMed ID: 24614355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term mechanical unloading and reverse remodeling of failing hearts in children.
    Mohapatra B; Vick GW; Fraser CD; Clunie SK; Towbin JA; Sinagra G; Vatta M
    J Heart Lung Transplant; 2010 Jan; 29(1):98-104. PubMed ID: 19783184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
    Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems.
    Sodian R; Loebe M; Schmitt C; Potapov EV; Siniawski H; Müller J; Hausmann H; Zurbruegg HR; Weng Y; Hetzer R
    J Am Coll Cardiol; 2001 Dec; 38(7):1942-9. PubMed ID: 11738298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomarker responses during mid-term mechanical cardiac support in children.
    Heise G; Lemmer J; Weng Y; Hübler M; Alexi-Meskishvili V; Böttcher W; Hetzer R; Berger F; Stiller B
    J Heart Lung Transplant; 2008 Feb; 27(2):150-7. PubMed ID: 18267220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-type natriuretic peptide predicts postoperative cardiac events and mortality after elective open abdominal aortic aneurysm repair.
    Bryce GJ; Payne CJ; Gibson SC; Byrne DS; Delles C; McClure J; Kingsmore DB
    J Vasc Surg; 2013 Feb; 57(2):345-53. PubMed ID: 23058722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should patients 60 years and older undergo bridge to transplantation with continuous-flow left ventricular assist devices?
    Allen JG; Kilic A; Weiss ES; Arnaoutakis GJ; George TJ; Shah AS; Conte JV
    Ann Thorac Surg; 2012 Dec; 94(6):2017-24. PubMed ID: 22858277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Humoral and hemodynamic responses after left ventricular assist device implantation and heart transplantation.
    Wagner FD; Buz S; Zais H; Stasch JP; Hetzer R; Hocher B
    Exp Biol Med (Maywood); 2006 Jun; 231(6):861-4. PubMed ID: 16741013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
    Klotz S; Danser AH; Foronjy RF; Oz MC; Wang J; Mancini D; D'Armiento J; Burkhoff D
    J Am Coll Cardiol; 2007 Mar; 49(11):1166-74. PubMed ID: 17367660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical implication of blood levels of B-type natriuretic peptide in pediatric patients on mechanical circulatory support.
    Huang SC; Wu ET; Ko WJ; Lai LP; Hsu J; Chang CI; Chiu IS; Wang SS; Wu MH; Lin FY; Chen YS
    Ann Thorac Surg; 2006 Jun; 81(6):2267-72. PubMed ID: 16731165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive value of the Seattle Heart Failure Model in patients undergoing left ventricular assist device placement.
    Ketchum ES; Moorman AJ; Fishbein DP; Mokadam NA; Verrier ED; Aldea GS; Andrus S; Kenyon KW; Levy WC
    J Heart Lung Transplant; 2010 Sep; 29(9):1021-5. PubMed ID: 20558086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Predictive value for long term cardiac events by admission B-type natriuretic peptide and pulmonary capillary wedge pressure in patients with chronic heart failure].
    Hu YM; Wang M; Zhao SQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Sep; 36(9):786-9. PubMed ID: 19102857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.